Synokem Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1983.
1983 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Synokem Pharmaceuticals Limited

Synokem Pharmaceuticals Limited, a active public limited company, was established on 18 August 1983 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U21002DL1983PLC016353. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.82 Cr.

Formerly known as Synokem Pharmaceuticals Private Limited. It upholds a compliant status. Employing 363 professional, Its leadership includes Gajanan Mohan Shenoy (Director), Vishal Gupta (Nominee Director), Abhinav Arora (Managing Director). Past directors included Sonam Bansal, Anmol Srivastava, Gajanan Mohan Shenoy. It holds ₹200.00 Cr open charges and ₹14.75 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 14/486 , Basement & Ground Floor, Outer Ring Road, Paschim Vihar, New Delhi, Delhi, 110087.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002DL1983PLC016353

  • Registration Number

    016353

  • Incorporation Date

    18 August 1983

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹4.82 Cr

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 4.82 Cr
  • Company Age 42 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 200.00 Cr
  • Satisfied Charges ₹ 14.75 Cr
  • Revenue Growth **** -12.18%
  • Profit Growth **** -9.62%
  • Ebitda **** -4.43%
  • Net Worth 16.16%
  • Total Assets **** 13.22%
Company report

Synokem Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Synokem Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synokem Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Gajanan Mohan Shenoy Director 30 Mar 2024 Current
Vishal Gupta Nominee Director 18 Jan 2023 Current
Abhinav Arora Managing Director 01 Jul 2005 Current
Thomas Baby Director 01 Jul 2019 Current
Shubhangi Agarwal Director 01 Apr 2022 Current
Dhiraj Poddar Nominee Director 24 Jul 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2022 Past
Pramod Abcsdd Director 18 Jan 2023 Past
Pramod Abcsdd Additional Director 07 Apr 2024 Past
Pramod Abcsdd Additional Director 18 Jan 2023 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 27 Dec 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synokem Pharmaceuticals.

Synokem Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.18% decrease. The company also saw a slight decrease in profitability, with a 9.62% decrease in profit. The company's net worth Soared by an impressive increase of 16.16%.

Synokem Pharmaceuticals revenue growth over time
Synokem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -12.18%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.86%
*******
*******
*******
*******
Total Assets
*******
 13.22%
*******
*******
*******
*******
Profit or Loss
*******
 -9.62%
*******
*******
*******
*******
Net Worth
*******
 16.16%
*******
*******
*******
*******
EBITDA
*******
 -4.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synokem Pharmaceuticals?

In 2025, Synokem Pharmaceuticals had a promoter holding of 98.00% and a public holding of 2.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,000,000,000.00

Satisfied Charges

₹147,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 177.50 Cr
  • Axis Bank Limited : 22.50 Cr
Latest Charge Details
Date Lender Amount Status
10 Mar 2026 Others ₹15.00 Cr Open
31 Jul 2024 Axis Bank Limited ₹22.50 Cr Open
06 May 2024 Others ₹15.00 Cr Open
16 Jan 2024 Others ₹20.00 Cr Open
22 Sep 2023 Others ₹115.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Synokem Pharmaceuticals?

Synokem Pharmaceuticals has a workforce of 363 employees as of Oct 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synokem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synokem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synokem Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101263462 was registered on 10 Mar 2026. was completed.

  • Director Appointment

    Yugal Kishor Chothuram Sikri was appointed as a Nominee Director was appointed as a Nominee Director on 31 Jan 2026 & has been associated with this company since 3 months 11 days . was recorded as a recent event.

  • Annual General Meeting

    Synokem Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 12.50 Cr registered on 16 Feb 2009 with Charge ID 10145202 was modified on 26 Aug 2025. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited of Rs. 22.50 Cr registered on 31 Jul 2024 with Charge ID 100961273 was modified on 15 Apr 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Synokem Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synokem Pharmaceuticals Limited?

The CIN of Synokem Pharmaceuticals Limited is U21002DL1983PLC016353.

Where is Synokem Pharmaceuticals Limited headquartered?

Synokem Pharmaceuticals Limited is headquartered at 14/486 , Basement & Ground Floor, Outer Ring Road, Paschim Vihar, New Delhi, Delhi, 110087.

When was Synokem Pharmaceuticals Limited incorporated?

Synokem Pharmaceuticals Limited was incorporated on 18 August 1983.

Who are the current directors of Synokem Pharmaceuticals Limited?

The current directors of Synokem Pharmaceuticals Limited are

What is the primary industry of Synokem Pharmaceuticals Limited?

The primary industry of Synokem Pharmaceuticals Limited is Manufacturing.

Is Synokem Pharmaceuticals Limited a listed company?

Synokem Pharmaceuticals Limited is unlisted.

What is the capital structure of Synokem Pharmaceuticals Limited?

The authorized capital of Synokem Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹4.82 Cr.

What is the compliance status of Synokem Pharmaceuticals Limited?

The compliance status of Synokem Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available